共 50 条
- [13] Matching-Adjusted Indirect Comparison of Etrasimod Versus Ozanimod for Clinical Response and Remission Among Patients With Moderately to Severely Active Ulcerative Colitis AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1058 - S1059
- [18] Upadacitinib improves symptomatic responses in patients with moderately to severely active Crohn's disease JOURNAL OF CROHNS & COLITIS, 2024, 18 : II000 - I1001